The investment will finance clinical development of AstroRx for the treatment of ALS and to begin the clinical development of IsletRx, as a cure for insulin-dependent diabetes.
Perrigo is delisting its shares from the TASE after divesting its Israeli-based operations earlier this year.
The Israeli company's masks include treated fabric with a very high effectiveness level in neutralizing the Covid pandemic's Delta variant.
To fix Israel's atrocious record, Deputy Minister of the Economy Yair Golan is promoting a single authority covering all aspects of safety at work.
Berkshire Hathaway is down an estimated $350 million 'on paper' on its investment in Teva.
Former Hadassah Hospital CEO Zeev Rotstein has joined the board of Israeli solid tumor treatment startup New Phase.
AION Labs will set Israeli computing talent to solving international pharma companies' problems. CEO Mati Gill and adviser Christian Tidona explain.
Perrigo to delist from TASE